References
- Baman TS, Jongnarangsin K, Chugh A, Suwanagool A, Guiot A, Madenci A, et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:626–31.
- Bodhey NK, Gupta AK, Sreedhar R, Manohar SR. Retroperitoneal hematoma: An unusual complication after femoral vein cannulation. J Cardiothorac Vasc Anesth. 2006; 20:859–61.
- Klonaris C, Katsargyris A, Vasileiou I, Markatis F, Liapis CD, Bastounis E. Hybrid repair of ruptured infected anastomotic femoral pseudoaneurysms: Emergent stent-graft implantation and secondary surgical debridement. J Vasc Surg. 2009; 49:938–45.
- Reddy YM, Singh D, Chikkam V, Bommana S, Atkins D, Verma A, et al. Postprocedural neuropathy after atrial fibrillation ablation. J Interv Card Electrophysiol. 2013; 36:279–85.
- Andersen K, Bregendahl M, Kaestel H, Skriver M, Ravkilde J. Haematoma after coronary angiography and percutaneous coronary intervention via the femoral artery frequency and risk factors. Eur J Cardiovasc Nurs. 2005;4:123–7.
- Kumar S. Location of femoral artery access and correlation with vascular complications. Catheter Cardiovasc Interv. 2011.
- Mulder AA, Balt JC, Wijffels MC, Wever EF, Boersma LV. Safety of pulmonary vein isolation and left atrial complex fractionated atrial electrograms ablation for atrial fibrillation with phased radiofrequency energy and multi-electrode catheters. Europace. 2012;14:1433–40.
- Kugelmass AD, Cohen DJ, Brown PP, Simon AW, Becker ER, Culler SD. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol. 2006;97:322–7.
- Prudente LA, Moorman JR, Lake D, Xiao Y, Greebaum H, Mangrum JM, et al. Femoral vascular complications following catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2009;26:59–64.
- Hoyt H, Bhonsale A, Chilukuri K, Alhumaid F, Needleman M, Edwards D, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8:1869–74.
- Hakalahti A, Uusimaa P, Ylitalo K, Raatikainen MJ. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace. 2011;13:640–5.
- Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C, Thomas S. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:361.
- Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the heart rhythm society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2012;9:632, 696.e21.
- Rivera S, Dussault C, Ayala-Peredes F, Badra-Vardu M, Roux J. Comparison of two procedural anticoagulation regimens for patients undergoing left-sided ablation procedures. Heart Rhythm. 2013;10:S235–90.
- Sairaku A, Nakano Y, Oda N, Makita Y, Kajihara K, Tokuyama T, et al. Rapid hemostasis at the femoral venous access site using a novel hemostatic pad containing kaolin after atrial fibrillation ablation. J Interv Card Electrophysiol. 2011;31:157–64.
- Mahadevan VS, Jimeno S, Benson LN, McLaughlin PR, Horlick EM. Pre-closure of femoral venous access sites used for large-sized sheath insertion with the perclose device in adults undergoing cardiac intervention. Heart. 2008;94: 571–2.
- Santangeli P, Di Biase L, Horton R, Burkhardt JD, Sanchez J, Al-Ahmad A, et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: Evidence from a meta-analysis. Circ Arrhythm Electrophysiol. 2012;5:302–11.